NCT05534594View on ClinicalTrials.gov

Evaluation of the 18F-PSMA Positron Emission Tomography (PET)/CT in Patients With Medullary Thyroid Cancer

NACompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

August 19, 2022

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Medullary Thyroid CancerMedullary Thyroid CarcinomaThyroid Carcinoma, MedullaryThyroid Cancer, Medullary
Interventions
DRUG

18F-PSMA-1007

As explained under 'Arms'.

Trial Locations (1)

9713 GZ

University Medical Centre Groningen, Groningen

All Listed Sponsors
lead

University Medical Center Groningen

OTHER